KENNETH C FRAZIER

CIK 1181175 · Executive Chair · last filed 2026-03-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$115.97M

Companies

4

Total Filings

93

Lifetime Open-Market Net

-$453.27M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EIKN Director 111,111 $8.75 $972.2K $2.00M 2 2026-03-04
MRK Executive Chair 915,989 $119.05 $109.05M -$455.27M 71 2022-11-08
XOM Director 40,500 $147.01 $5.95M $0 15 2022-05-26
Merck & Co., Inc. (MRKpB) Delisted President 149,836 $0 5 2010-08-03

Recent Filings · Page 2 of 10

93 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-01-04 XOM Grant (A) +2,500 $0 EDGAR
2021-11-10 MRK Mixed -$54.61M EDGAR
2021-05-06 MRK Grant (A) $0 EDGAR
2021-03-02 MRK Grant (A) +175,249 $12.73M EDGAR
2021-01-06 XOM Grant (A) +2,500 $0 EDGAR
2020-11-12 MRK Sell (S) −280,000 -$22.80M EDGAR
2020-05-05 MRK Grant (A) $0 EDGAR
2020-03-03 MRK Grant (A) +119,291 $9.13M EDGAR
2020-01-03 XOM Grant (A) +2,500 $0 EDGAR
2019-05-09 MRK Gift (G) −14,623 $0 EDGAR
Showing 1120 of 93
Page 2 of 10
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.